ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
-13.88%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$38.4M
AUM Growth
+$38.4M
(-42%)
Cap. Flow
-$22M
Cap. Flow
% of AUM
-57.37%
Top 10 Holdings %
Top 10 Hldgs %
85.77%
Holding
21
New
4
Increased
5
Reduced
7
Closed
5
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.71M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
$1.65M |
| 3 |
XNPT
XENOPORT, INC.
XNPT
|
$1.5M |
| 4 |
Amicus Therapeutics
FOLD
|
$1.17M |
| 5 |
Neurocrine Biosciences
NBIX
|
$882K |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$7.68M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$6.23M |
| 3 |
Centene
CNC
|
$4.58M |
| 4 |
Edwards Lifesciences
EW
|
$2.77M |
| 5 |
Alkermes
ALKS
|
$2.33M |
Sector Composition
| 1 | Healthcare | 69.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XNPT
1
DELISTED
XENOPORT, INC.
XNPT
| $7.34M | 19.13% | 1,627,628 +331,850 | +26% | +$1.5M |
|
|
2
Eli Lilly
LLY
$657B
| $4.71M | 12.28% | +65,400 | New | +$4.71M |
|
3
Quest Diagnostics
DGX
$20.3B
| $4.54M | 11.85% | 63,595 -29,850 | -32% | -$2.13M |
|
|
4
Amicus Therapeutics
FOLD
$2.34B
| $2.82M | 7.35% | 333,513 +138,307 | +71% | +$1.17M |
|
|
NVRO
5
DELISTED
NEVRO CORP.
NVRO
| $2.78M | 7.24% | 49,377 -5,550 | -10% | -$312K |
|
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $2.5M | 6.51% | 63,188 +22,300 | +55% | +$882K |
|
7
UnitedHealth
UNH
$281B
| $2.31M | 6.01% | 17,900 -17,786 | -50% | -$2.29M |
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $2.21M | 5.76% | 41,286 -34,000 | -45% | -$1.82M |
|
|
IPXL
9
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.99M | 5.18% | 62,050 +10,620 | +21% | +$340K |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.71M | 4.46% | 140,587 +54,692 | +64% | +$665K |
|
|
11
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.65M | 4.29% | +12,050 | New | +$1.65M |
|
|
12
Edwards Lifesciences
EW
$47.8B
| $1.39M | 3.63% | 15,780 -31,450 | -67% | -$2.77M |
|
|
13
Centene
CNC
$14.3B
| $730K | 1.9% | 11,850 -74,289 | -86% | -$4.58M |
|
14
QuidelOrtho
QDEL
$1.95B
| $717K | 1.87% | +41,550 | New | +$717K |
|
15
OraSure Technologies
OSUR
$242M
| $500K | 1.3% | +69,200 | New | +$500K |
|
|
ANAC
16
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $473K | 1.23% | 8,850 -6,741 | -43% | -$360K |
|
|
17
Alkermes
ALKS
$4.78B
| – | – | -29,350 | Closed | -$2.33M |
|
18
Pacific Biosciences
PACB
$393M
| – | – | -145,306 | Closed | -$1.91M |
|
|
19
PTC Therapeutics
PTCT
$3.92B
| – | – | -237,100 | Closed | -$7.68M |
|
|
ACOR
20
DELISTED
Acorda Therapeutics, Inc.
ACOR
| – | – | -145,509 | Closed | -$6.23M |
|
|
SGYP
21
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| – | – | -303,157 | Closed | -$1.72M |
|